LEVY ADAM D. (Chief Financial Officer) sold 1.7% of their position (1.14K shares) of ACRIVON THERAPEUTICS, INC. on the open market
Open‑market sale worth $1.8K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 8/6/2026ACC: 0000905148-26-003499
Officer· Chief Financial Officer
Since Mar 2026
-1.14K
Net shares
Net seller
$1.8K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.14K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.14K
Price / share
$1.57
Trade value
$1.79K
% of position
1.7%
8/4/2026
67.15K→66.01K
Total
Net shares
−1.14K
Net value
-$1.79K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 8/4/2026 | S · Sale | −1.14K | $1.57 | $1.79K | 1.7% | 67.15K | 66.01K |
| Total | −1.14K | -$1.79K | ||||||
Derivative Transactions0
No derivative transactions reported